• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, June 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Structural Heart features studies on ASD closure and disparities in Watchman device access

Bioengineer by Bioengineer
March 12, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

NEW YORK – March 12, 2019-The Cardiovascular Research Foundation (CRF) is pleased to announce that the latest issue of Structural Heart: The Journal of the Heart Team features original research articles on readmissions after atrial septal defect (ASD) closure and socioeconomic disparities in access to the Watchman device in patients with atrial fibrillation (AF).

Structural Heart, the official journal of CRF, is led by a distinguished Editorial Board of recognized international experts in the field. The journal is dedicated to disseminating the latest research and information to members of the Heart Team, as well as the wider medical community interested in structural heart disorders. The journal is now indexed on Embase, a biomedical research database from Elsevier.

“The second issue of Volume 3 features two research papers that may impact the treatment of atrial septal defects and atrial fibrillation,” said Anthony N. DeMaria, MD, Editor-in-Chief of the journal and the Judith and Jack White Chair in Cardiology and Founding Director of the Sulpizio Cardiovascular Center at the University of California, San Diego. “A paper by Mojadidi et al evaluates readmissions data after ASD closure and indicates that compared with surgical repairs, percutaneous ASD closures are associated with lower all-cause mortality, major and minor complications, and length of hospital stay. A paper by Kupsky et al examines data regarding racial, economic, and social disparities in AF patients at elevated risk for bleeding referred to Watchman insertion.”

Below are brief descriptions of the two original articles highlighted in this issue.

Incidence and Causes of 30-day Readmissions after Surgical Versus Percutaneous Secundum Atrial Septal Defect Closure: A United States Nationwide Analysis

M. Mojadidi et al.

Editorial: As If Percutaneous ASD Closure Needed More Proof

T. Jones

Researchers evaluated the incidence and reasons of 30-day readmissions following surgical versus percutaneous secundum ASD closure. They found that percutaneous ASD closure is associated with lower rates of 30-day readmissions, mean length of hospital stay, and hospital charges as compared with surgical closure.

Socioeconomic Disparities in Access for Watchman Device Insertion in Patients with Atrial Fibrillation and at Elevated Risk of Bleeding

D. Kupsky et al.

This single-center retrospective case-control study examined socioeconomic and racial disparities among select atrial fibrillation (AF) patients who did or did not receive Watchman device placement. Researchers found that socioeconomic and racial disparities exist in patients with non-valvular AF at elevated risk of bleeding. African-American patients with lower income and Medicaid were less likely to be referred for the Watchman device.

###

About CRF and Structural Heart

The Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve the survival and quality of life for people suffering from heart and vascular disease. For over 25 years, CRF has helped pioneer innovations in interventional cardiology and has educated doctors on the latest treatments for heart disease. For more information, visit http://www.crf.org.

Structural Heart: The Journal of the Heart Team is the official journal of CRF. It is a unique, international, and peer-reviewed journal focusing on the diagnosis and treatment of diseases of the heart valves, myocardium, and great vessels, as well as congenital heart disease. The journal covers topics such as transcatheter procedures, cardiovascular surgery, drug treatment, basic and translational science, imaging, and innovation (new devices, therapies, and first-in-man). The journal is now indexed on Embase, a biomedical research database from Elsevier. For more information, visit http://www.crf.org/crf/shj.

Media Contact
Judy Romero
[email protected]
https://www.crf.org/crf/news-and-events/news/news/3050-latest-issue-of-structural-heart-features-research-on-readmissions-after-atrial-septal-defect-closure-and-socioeconomic-disparities-in-watchman-device-access-in-patients-with-atrial-fibrillation

Tags: CardiologyClinical TrialsEducationMedical EducationMedicine/HealthMortality/Longevity
Share13Tweet8Share2ShareShareShare2

Related Posts

Tracking Lanthanide-Labeled Microplastics in Plants

June 25, 2026

Neural Design Enables Zero-Shot Drug-Binding Proteins

June 25, 2026

Genomic Insights into Human Skin Fungi Diversity

June 25, 2026

Chiral Laser Gyroscopes Surpass Lock-In Limit

June 25, 2026
Please login to join discussion

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracking Lanthanide-Labeled Microplastics in Plants

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.